home / stock / cori / cori quote
Last: | $ |
---|---|
Change Percent: | 0.24% |
Open: | $12.67 |
Close: | $12.68 |
High: | $12.745 |
Low: | $12.65 |
Volume: | 4,072,230 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $12.67 | $12.68 | $12.745 | $12.65 | 4,072,230 | 11-26-2018 |
$ | $12.66 | $12.65 | $12.68 | $12.64 | 598,882 | 11-23-2018 |
$ | $12.67 | $12.71 | $12.71 | $12.64 | 377,910 | 11-21-2018 |
$ | $12.68 | $12.67 | $12.68 | $12.64 | 427,780 | 11-20-2018 |
$ | $12.65 | $12.67 | $12.69 | $12.65 | 221,549 | 11-19-2018 |
$ | $12.62 | $12.65 | $12.66 | $12.62 | 439,205 | 11-16-2018 |
$ | $12.62 | $12.63 | $12.66 | $12.62 | 344,620 | 11-15-2018 |
$ | $12.62 | $12.64 | $12.65 | $12.62 | 188,697 | 11-14-2018 |
$ | $12.61 | $12.64 | $12.64 | $12.61 | 204,907 | 11-13-2018 |
$ | $12.60 | $12.60 | $12.62 | $12.59 | 516,613 | 11-12-2018 |
$ | $12.61 | $12.60 | $12.63 | $12.60 | 493,754 | 11-09-2018 |
$ | $12.60 | $12.61 | $12.62 | $12.59 | 370,929 | 11-08-2018 |
$ | $12.61 | $12.61 | $12.63 | $12.59 | 589,244 | 11-07-2018 |
$ | $12.59 | $12.60 | $12.61 | $12.59 | 441,204 | 11-06-2018 |
$ | $12.60 | $12.60 | $12.61 | $12.58 | 433,159 | 11-05-2018 |
$ | $12.63 | $12.59 | $12.63 | $12.58 | 608,770 | 11-02-2018 |
$ | $12.64 | $12.61 | $12.68 | $12.58 | 691,694 | 11-01-2018 |
$ | $12.62 | $12.65 | $12.66 | $12.60 | 533,319 | 10-31-2018 |
$ | $12.61 | $12.60 | $12.63 | $12.58 | 562,848 | 10-30-2018 |
$ | $12.63 | $12.61 | $12.67 | $12.57 | 503,741 | 10-29-2018 |
News, Short Squeeze, Breakout and More Instantly...
Corium International Inc. Company Name:
CORI Stock Symbol:
NASDAQ Market:
Corium International Inc. Website:
MENLO PARK, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development of novel transdermal healthcare products that are intended to provide alternative treatment options for patients and their families, today announced that ...
MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Corium, Inc. announced today that its Board of Directors has named Perry Sternberg as Chief Executive Officer. Mr. Sternberg is a senior pharmaceutical executive with commercial experience across a wide range of therapeutic areas ...
MENLO PARK, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc., a Delaware corporation (“Corium”, the “Issuer”, “we”, “us” or “our”), today announced that, as a result of its acquisition by Gurnet Point ...